CHU Dinant Godinne UCL Namur

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.4193/rhin20.600 European Position Paper on Rhinosinusitis and Nasal Polyps 2020
https://doi.org/10.1007/s005860050038 Pelvic incidence: a fundamental pelvic parameter for three-dimensional regulation of spinal sagittal curves
https://doi.org/10.1055/b-0034-97635 European Position Paper on Rhinosinusitis and Nasal Polyps
https://doi.org/10.1007/s004050000299 A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques
https://doi.org/10.1016/j.taap.2005.01.008 Respiratory toxicity of multi-wall carbon nanotubes
https://doi.org/10.1128/aac.43.4.727 Aminoglycosides: Activity and Resistance
https://doi.org/10.1016/s0140-6736(10)62175-7 Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial
https://doi.org/10.1056/nejmoa1714678 Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
https://doi.org/10.1016/s0140-6736(19)31240-1 Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
https://doi.org/10.1016/j.crohns.2013.12.013 Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
https://doi.org/10.1093/annonc/mdv304 Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
https://doi.org/10.1016/s0140-6736(07)61537-2 Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trial
https://doi.org/10.1038/s41564-019-0492-8 Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread
https://doi.org/10.1016/s1473-3099(16)30257-2 Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study
https://doi.org/10.1093/annonc/mdu181 Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
https://doi.org/10.1183/09031936.00105513 Respiratory health and disease in Europe: the new European Lung White Book
https://doi.org/10.1093/ecco-jcc/jjab052 ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease
https://doi.org/10.1038/ng1425 Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia
https://doi.org/10.1093/annonc/mdy080 Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
https://doi.org/10.1182/blood-2010-06-294108 CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients
https://doi.org/10.1016/s1470-2045(21)00007-3 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
https://doi.org/10.1093/ecco-jcc/jjv227 Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease
https://doi.org/10.1186/1475-925x-10-1 Feature extraction and selection for objective gait analysis and fall risk assessment by accelerometry
https://doi.org/10.1182/blood-2008-04-153189 Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study
https://doi.org/10.1056/nejmoa042040 ACVBP versus CHOP plus Radiotherapy for Localized Aggressive Lymphoma
https://doi.org/10.1182/blood-2003-02-0542 Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma
https://doi.org/10.1007/s12603-019-1196-8 Exercise Interventions for the Prevention and Treatment of Sarcopenia. A Systematic Umbrella Review
https://doi.org/10.1182/blood-2011-05-355081 Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma
https://doi.org/10.1016/s1470-2045(13)70122-0 Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial
https://doi.org/10.1007/s00405-007-0279-z Proposal for revision of the European Laryngological Society classification of endoscopic cordectomies
https://doi.org/10.1016/s0140-6736(23)00772-9 Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
https://doi.org/10.21037/jtd.2018.02.43 Fifty years of coronary artery bypass grafting
https://doi.org/10.1210/jcem.82.7.4088 Sex-Related Difference in the Growth of Prolactinomas: A Clinical and Proliferation Marker Study1
https://doi.org/10.1200/jco.19.01073 Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study
https://doi.org/10.1136/gutjnl-2021-324032 Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community
https://doi.org/10.1182/blood-2014-09-599894 Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia
https://doi.org/10.1016/j.ejca.2018.11.015 Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy
https://doi.org/10.1111/j.1365-2141.2009.07740.x A Phase II study of SGN‐30 (anti‐CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma
https://doi.org/10.1155/2014/347031 Erratum to “Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants”
https://doi.org/10.1016/j.lungcan.2011.10.017 The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group
https://doi.org/10.1200/jco.2006.09.2940 Magnetic Resonance Imaging of the Axial Skeleton for Detecting Bone Metastases in Patients With High-Risk Prostate Cancer: Diagnostic and Cost-Effectiveness and Comparison With Current Detection Strategies
https://doi.org/10.1160/th12-12-0898 Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide
https://doi.org/10.1016/s1474-4422(15)00216-1 Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial
https://doi.org/10.1136/bmj.n1585 Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial
https://doi.org/10.1007/s00268-002-6705-x Factors Affecting Mortality in Generalized Postoperative Peritonitis: Multivariate Analysis in 96 Patients
https://doi.org/10.1007/s00415-020-10108-x Immune-mediated neurological syndromes in SARS-CoV-2-infected patients
https://doi.org/10.1111/apt.12937 Olmesartan-associated enteropathy: results of a national survey
Sagittal plane alignment of the spine and gravity: a radiological and clinical evaluation.
https://doi.org/10.1136/jitc-2020-001749 Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy
https://doi.org/10.1038/sj.bjc.6605979 Cancer and renal insufficiency results of the BIRMA study
https://doi.org/10.4244/eijv8i12a209 The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients
https://doi.org/10.1038/ng.587 Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia
https://doi.org/10.1200/jco.21.01815 Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)
https://doi.org/10.1016/j.jaci.2006.03.048 Natural rubber latex allergy among health care workers: A systematic review of the evidence
https://doi.org/10.1007/s002040050380 Influence of the route of administration and the chemical form (MnCl 2 , MnO 2 ) on the absorption and cerebral distribution of manganese in rats
https://doi.org/10.1007/s00277-007-0399-y Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP
https://doi.org/10.3324/haematol.2013.090597 Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial
https://doi.org/10.1093/annonc/mds273 Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
https://doi.org/10.1038/ajg.2017.501 Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study
https://doi.org/10.1016/j.cgh.2010.07.022 Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti–Tumor Necrosis Factor Therapy
https://doi.org/10.1183/09031936.00135814 Imprinting of the COPD airway epithelium for dedifferentiation and mesenchymal transition
https://doi.org/10.1093/jac/dkt344 Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria
https://doi.org/10.1093/jac/dkp355 An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients
https://doi.org/10.3389/fnhum.2012.00343 Dual-tDCS Enhances Online Motor Skill Learning and Long-Term Retention in Chronic Stroke Patients
https://doi.org/10.1111/j.1742-1241.2008.01911.x Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club
https://doi.org/10.1093/jac/dks156 Evaluation of a DNA microarray for the rapid detection of extended-spectrum  -lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM)
https://doi.org/10.1007/s40266-014-0157-5 Reduction of Potentially Inappropriate Medications Using the STOPP Criteria in Frail Older Inpatients: A Randomised Controlled Study
https://doi.org/10.1186/s12959-016-0123-z Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories
https://doi.org/10.1128/jcm.01234-10 Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification ofNocardiaSpecies
https://doi.org/10.1093/jac/dkad139 Invasive candidiasis: current clinical challenges and unmet needs in adult populations
https://doi.org/10.1093/annonc/mdv268 Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study
https://doi.org/10.1182/blood-2009-10-246470 Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study
https://doi.org/10.1016/j.jacc.2010.12.045 Syncope Due to Idiopathic Paroxysmal Atrioventricular Block
https://doi.org/10.1016/j.wneu.2012.11.003 Evaluation of the Quality of Information on the Internet Available to Patients Undergoing Cervical Spine Surgery
https://doi.org/10.1183/09031936.97.10112612 Inhalation challenges with agents causing occupational asthma
https://doi.org/10.1016/j.jpeds.2016.05.027 Effect of Intra- and Extrauterine Growth on Long-Term Neurologic Outcomes of Very Preterm Infants
https://doi.org/10.1016/j.rehab.2020.04.001 The role of physical and rehabilitation medicine in the COVID-19 pandemic: The clinician's view
https://doi.org/10.3389/fphys.2021.691227 Epithelial Barrier Dysfunction in Chronic Respiratory Diseases
https://doi.org/10.1001/jama.2019.14607 Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock
https://doi.org/10.1111/apt.15539 Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti‐TNF or conventional therapy: results of the European CONCEIVE study
https://doi.org/10.1093/jac/dkt065 Validation of carbapenemase and extended-spectrum  -lactamase multiplex endpoint PCR assays according to ISO 15189
https://doi.org/10.1128/jcm.02607-10 Evaluation of a DNA Microarray (Check-MDR CT102) for Rapid Detection of TEM, SHV, and CTX-M Extended-Spectrum β-Lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 Carbapenemases
https://doi.org/10.1007/s00520-008-0430-4 Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia study
https://doi.org/10.1016/j.ejca.2013.04.029 A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid®) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: The EXPECT trial
https://doi.org/10.23736/s1973-9087.20.06317-0 COVID-19 pandemic. What should Physical and Rehabilitation Medicine specialists do? A clinician's perspective
https://doi.org/10.1038/leu.2014.332 Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years
https://doi.org/10.1164/rccm.201010-1629oc Bronchial Secretory Immunoglobulin A Deficiency Correlates With Airway Inflammation and Progression of Chronic Obstructive Pulmonary Disease
https://doi.org/10.1182/blood-2011-07-370247 Autologous peripheral blood stem cell transplantation for acute myeloid leukemia
https://doi.org/10.1182/blood-2010-08-300863 Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial
https://doi.org/10.1093/annonc/mds057 Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers
https://doi.org/10.1016/j.ejvs.2014.12.031 Epidemiological Study on Chronic Venous Disease in Belgium and Luxembourg: Prevalence, Risk Factors, and Symptomatology
https://doi.org/10.1177/1545968314562109 Hand and Arm Bimanual Intensive Therapy Including Lower Extremity (HABIT-ILE) in Children With Unilateral Spastic Cerebral Palsy
https://doi.org/10.1016/j.exger.2010.08.009 Serum N-glycan profile shift during human ageing
https://doi.org/10.1182/blood.2019001904 Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.
https://doi.org/10.1128/jcm.03467-14 Efficient Detection of Carbapenemase Activity in Enterobacteriaceae by Matrix-Assisted Laser Desorption Ionization−Time of Flight Mass Spectrometry in Less Than 30 Minutes
https://doi.org/10.1038/leu.2010.110 Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy
https://doi.org/10.1093/ecco-jcc/jjz080 Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn’s Disease Who Failed Biologic Therapies: A National Cohort Study
https://doi.org/10.1111/ejh.12543 Pathophysiology, diagnosis, and treatment of paroxysmal nocturnal hemoglobinuria: a review
https://doi.org/10.1530/eje.0.1340454 Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine
https://doi.org/10.1016/s1470-2045(23)00396-0 Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial